---
title: "Drug Discovery Advancement Consultancy"
ocid: "ocds-r6ebe6-0000846686"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000846686"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000846686.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000846686.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "University Of Edinburgh"
published: "2026-10-28"
---

# Drug Discovery Advancement Consultancy

Buyer: University Of Edinburgh  
Current stage: Award  
OCID: ocds-r6ebe6-0000846686

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000846686)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000846686.json)

## Summary

The University of Edinburgh commissioned the Baillie Gifford Pandemic Sciences Hub’s drug discovery and development consultancy. The work covers specialised strategic advice, with support for creating spinouts and commercialising research. It is aimed at advancing the Hub’s drug discovery and development work and is delivered in Edinburgh. This is a specialist professional services requirement, rather than a purchase of medicines or laboratory equipment.

The procurement is complete and the contract is active. Future Bio Consulting Ltd was selected for the single lot through a limited procedure without prior publication of a competition. The University justified this route on technical grounds, citing the consultant’s combined specialist skills and project-specific knowledge. The contract was signed on 26 October 2026 and is valued at £286,440. Its initial term is 42 months, with one optional six-month extension, giving a maximum possible term of 48 months. The published information does not give a separate award date. The selection was based on the University’s assessment that the consultant’s expertise was uniquely suited to meeting the project requirements.

For a future requirement of this kind, a credible supplier would need to combine scientific and medical understanding of drug discovery and development with commercial advisory experience. The buyer’s stated needs also point to capability in therapeutic innovation, integrating artificial intelligence, building strategic collaborations and mobilising resources. Experience translating research into spinouts and commercial outcomes would be relevant, alongside the ability to advise strategically across these areas rather than provide a narrow, single-discipline service. The appointment demonstrates demand for highly tailored consultancy supporting a university pandemic-sciences hub. Suppliers should be able to show that their expertise and knowledge fit the buyer’s specific project context, since the University relied on this combination of specialist skills when selecting its consultant.

## Notice

This University of Edinburgh requires highly specialised drug discovery and development consultancy including spinout and commercialisation support.

### Lot Information

Lot 1

The Baillie Gifford Pandemic Sciences Hub intend to appoint Future Bio Consultancy to provide highly specialised strategic advisory services in drug discovery and development including associated spinout and commercialisation support. The University considers competition to be absent for technical reasons as per Public Contracts (Scotland) Regulations 2015-33 (1) (b) (ii)Technical Reasons: The consultant identified possesses unique scientific, medical, commercial skills and project-specific knowledge (including therapeutic innovation, AI integration, strategic collaborations, and resource mobilisation) that are all required collectively to enable the University to meet its project requirements.

### Procurement Information

The Baillie Gifford Pandemic Sciences Hub intend to appoint Future Bio Consultancy to provide highly specialised strategic advisory services in drug discovery and development including associated spinout and commercialisation support. The University considers competition to be absent for technical reasons as per Public Contracts (Scotland) Regulations 2015-33 (1) (b) (ii)Technical Reasons: The consultant identified possesses unique scientific, medical, commercial skills and project-specific knowledge (including therapeutic innovation, AI integration, strategic collaborations, and resource mobilisation) that are all required collectively to enable the University to meet its project requirements.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT567536 |
| Notice type | OJEU - F15 - Voluntary Ex Ante Transparency Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 28 Oct 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £286,440 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | University Of Edinburgh |
| Locality | EDINBURGH |
| Postcode area | Edinburgh |
| Postcode | EH1 1HT |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | City Centre |
| Westminster constituency | Edinburgh East and Musselburgh |
| Delivery location | TLM75 City of Edinburgh |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | Future Bio Consulting Ltd |

## CPV Codes

### Divisions

- 73 - Research and development services and related consultancy services

### Codes

- 73000000 - Research and development services and related consultancy services

## Release History

- 28 Oct 2026 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT567536

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT567536
  Drug Discovery Advancement Consultancy - This University of Edinburgh requires highly specialised drug discovery and development consultancy including spinout and commercialisation support.

## Notice URLs

- http://
- http://www.ed.ac.uk
- http://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=846686
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000846686

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000846686. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000846686.json.
